Equibles does not estimate personal net worth.
Danish Qureshi was last confirmed as COO at LifeStance Health Group, Inc. (LFST) in a filing dated April 23, 2025. Earlier roles on record: COO at LifeStance Health Group, Inc. (LFST) until June 30, 2024. LifeStance Health Group, Inc. reported in an 8-K filed July 3, 2024 that Danish Qureshi was terminated as President and Chief Operating Officer, effective June 30, 2024. LifeStance Health Group, Inc. reported in an 8-K filed May 9, 2024 that Danish Qureshi resigned as President and Chief Operating Officer, effective June 30, 2024. The proxy statement of LifeStance Health Group, Inc. reports total compensation of $12,393,164 for Danish Qureshi in fiscal 2024, including a base salary of $211,449. Disclosed compensation is on record for 3 fiscal years. Danish Qureshi has spoken on 8 earnings calls across 1 company, most recently for LifeStance Health Group, Inc. on May 9, 2024. The companies whose calls Danish Qureshi spoke on are classified in the Healthcare sector.
“Effective as of June 30, 2024 (the "Separation Date"), Danish Qureshi's employment as President and Chief Operating Officer of LifeStance Health Group, Inc. ("LifeStance" or the "Company") terminated.”
“On May 6, 2024, Danish Qureshi, the President and Chief Operating Officer of LifeStance Health Group, notified the Company of his decision to depart the Company, effective June 30, 2024.”
“In March, we celebrated the 7-year anniversary of the founding of LifeStance. That's given me the chance to reflect on all that we have achieved over the years in service of our mission of increasing access to affordable mental health care.”
“We continued to align our teams around two growth priorities: net clinician adds and clinician productivity. We grew by 227 net clinician ads in the fourth quarter and 1014 for the full year, bringing our total clinicians to 6645, an increase of 18% year over year.”
“This year, we have focused on solidifying the foundation of our business. We have made significant upgrades in our senior operations leadership across the country and brought far more focus, prioritization, and data-driven decision-making to the organization in 2023.”
“We continue to align our teams around two growth priorities: net clinician ads and clinician productivity. In terms of net clinician ads, we grew by 171 in the second quarter, bringing our total to 6,132 clinicians, an increase of 17% year-over-year.”
“In addition to executing on the operational improvements and administrative simplification described by Ken and Dave, we continue to align our teams around two growth priorities: net clinician adds and clinician productivity.”
Proxy statement
Start not stated–2022-04-21
Last confirmed by a filing; no departure on record
Start not stated–2025-04-23
Last confirmed by a filing; no departure on record
Start not stated–2024-06-30
Medical Care Facilities · Healthcare
COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | LifeStance Health Group, Inc. (LFST) | Former President and Chief Operating Officer | $211,449 | $12,393,164 |
| 2023 | LifeStance Health Group, Inc. (LFST) | Former President and Chief Operating Officer | $345,385 | $3,738,662 |
| 2022 | LifeStance Health Group, Inc. (LFST) | Former President and Chief Operating Officer | $330,000 | $13,958,707 |
